Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol

INTRODUCTION: Cancer is a major health problem worldwide and the leading cause of death in many countries. The number of patients with cancer and socioeconomic costs of cancer continues to increase. SH003 is a novel herbal medicine consisting of Astragalus membranaceus, Angelica gigas and Trichosant...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Chunhoo, Kang, Sohyeon, Ko, Youme, Kim, Mia, Jang, Bo-Hyoung, Shin, Yong-Cheol, Ko, Seong-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078237/
https://www.ncbi.nlm.nih.gov/pubmed/30082340
http://dx.doi.org/10.1136/bmjopen-2017-019502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078237/
https://www.ncbi.nlm.nih.gov/pubmed/30082340
http://dx.doi.org/10.1136/bmjopen-2017-019502

Ejemplares similares